2019-12-16 11:37:00 Mon ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
America and China cannot decouple decades of long-term collaboration in trade, finance, and technology. In recent times, some economists claim that China may attempt to decouple decades of trade collaboration with the U.S. due to better tech supremacy on the eastern front. Several other economists further claim that China may try to revamp financial services and technological innovations well ahead of America.
Goldman Sachs chief strategy officer Stephanie Cohen indicates that these claims are overdone. In fact, Goldman continues to pursue fresh business opportunities in China after at least 2 decades of investment bank penetration there. In recent years, Goldman Sachs invests $60 million to bail out many depositors in Chinese brokerage firm Hainan Securities, which offers rich political connections in the one-party regime. Moreover, Goldman Sachs receives official approval from the China Securities Regulatory Commission (CSRC) to boost its equity stakes in Goldman Sachs Gao Hua Securities to the maximum cap of 51% from 33%. With managerial control over the joint venture, Goldman Sachs retains a key competitive advantage over its rivals such as JPMorgan Chase, UBS, and Nomura etc. This competitive edge empowers Goldman Sachs to further invest in Sino-American trade, finance, and technology in light of the new bilateral fair trade agreement.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic
2025-10-31 12:26:00 Friday ET

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi
2022-03-05 09:27:00 Saturday ET

Addendum on empirical tests of multi-factor models for asset return prediction Fama and French (2015) propose an empirical five-factor asset pricing mode
2018-09-05 08:34:00 Wednesday ET

Citron Research short-sellers initiate a class-action lawsuit against Tesla and its executive chairman Elon Musk because he might have deliberately orchestr
2018-06-08 13:35:00 Friday ET

The Federal Reserve delivers a second interest rate hike to 1.75%-2% and then expects subsequent rate increases in September and December 2018 to dampen inf
2019-03-25 17:30:00 Monday ET

America seeks to advance the global energy dominance agenda by toppling Saudi Arabia as the top oil exporter by 2024. The International Energy Agency (IEA)